These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3903631)

  • 1. Modern management of thalassemia.
    Festa RS
    Pediatr Ann; 1985 Sep; 14(9):597-600, 602-3, 606. PubMed ID: 3903631
    [No Abstract]   [Full Text] [Related]  

  • 2. The management of thalassemia major.
    Pearson HA; O'Brien RT
    Semin Hematol; 1975 Jul; 12(3):255-65. PubMed ID: 1079633
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical management of homozygous beta-thalassemia.
    Cividalli G
    Haematologica; 1979 Feb; 64(1):1-12. PubMed ID: 109360
    [No Abstract]   [Full Text] [Related]  

  • 4. Chelation therapy, transfusion requirement, and iron balance in young thalassemic patients.
    Piomelli S; Graziano J; Karpatkin M; Dudell GG; Hart D; Hilgartner M; Khanna K; Valdes-Cruz LM; Vora S
    Ann N Y Acad Sci; 1980; 344():409-17. PubMed ID: 6930881
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron chelating therapy in thalassemia: current problems.
    Russo G
    Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical management of beta-thalassemia.
    Graziano J; Piomelli S
    Tex Rep Biol Med; 1980-1981; 40():355-64. PubMed ID: 7034276
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome of thalassemia treated with conventional therapy.
    Borgna-Pignatti C; Zurlo MG; DeStefano P; Boffa C; DeSanctis V; DiPalma A; DiGregorio L; Melevendi C; Piga A; Sabato V
    Bone Marrow Transplant; 1993; 12 Suppl 1():2-4. PubMed ID: 8374554
    [No Abstract]   [Full Text] [Related]  

  • 8. Current concepts in the management of thalassemia.
    Festa RS
    Indian J Pediatr; 1987; 54(3):379-89. PubMed ID: 3301658
    [No Abstract]   [Full Text] [Related]  

  • 9. Desferrioxamine-induced iron outputs in Cooley's anemia. Results and perspectives.
    Cantore N; Tortarolo M; Volpe E; Gonnella F; Valente A; Buonanno G
    Haematologica; 1981 Apr; 66(2):196-207. PubMed ID: 6791996
    [No Abstract]   [Full Text] [Related]  

  • 10. The heart in thalassemia: a comprehensive review.
    Sahasakul Y; Chithiraphan S
    J Med Assoc Thai; 1985 Oct; 68(10):517-27. PubMed ID: 3908610
    [No Abstract]   [Full Text] [Related]  

  • 11. Some clinical features of Cooley's anemia patients as related to transfusion schedules.
    Wolman IJ; Ortolani M
    Ann N Y Acad Sci; 1969 Nov; 165(1):407-14. PubMed ID: 5260163
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of cardiac function in patients with thalassemia major.
    Nienhuis AW; Griffith P; Strawczynski H; Henry W; Borer J; Leon M; Anderson WF
    Ann N Y Acad Sci; 1980; 344():384-96. PubMed ID: 6930878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management of thalassemia. Decreasing iron stores during intensive chelation therapy.
    Cohen A; Schwartz E
    Ann N Y Acad Sci; 1980; 344():405-8. PubMed ID: 6930880
    [No Abstract]   [Full Text] [Related]  

  • 14. The natural history of thalassemia intermedia.
    Borgna-Pignatti C; Marsella M; Zanforlin N
    Ann N Y Acad Sci; 2010 Aug; 1202():214-20. PubMed ID: 20712795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.
    Kattamis CA; Kattamis AC
    Semin Hematol; 1995 Oct; 32(4):269-79. PubMed ID: 8560284
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of haemoglobinopathies.
    Davies SC; Wonke B
    Baillieres Clin Haematol; 1991 Apr; 4(2):361-89. PubMed ID: 1912665
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
    Borgna-Pignatti C; Rugolotto S; De Stefano P; Zhao H; Cappellini MD; Del Vecchio GC; Romeo MA; Forni GL; Gamberini MR; Ghilardi R; Piga A; Cnaan A
    Haematologica; 2004 Oct; 89(10):1187-93. PubMed ID: 15477202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria.
    Bannerman RM; Keusch G; Kreimer-Birnbaum M; Vance VK; Vaughan S
    Am J Med; 1967 Mar; 42(3):476-86. PubMed ID: 6019460
    [No Abstract]   [Full Text] [Related]  

  • 19. Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major.
    O'Brien RT
    Ann N Y Acad Sci; 1974; 232(0):221-5. PubMed ID: 4528431
    [No Abstract]   [Full Text] [Related]  

  • 20. Total management of thalassaemia major.
    Modell B
    Arch Dis Child; 1977 Jun; 52(6):489-500. PubMed ID: 879834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.